Moreover, mouse models lacking hepatic GHR, JAK2, or STAT5 have increased liver damage and develop features of NAFLD [49] suggesting GHR-JAK2-STAT5 impairment contributes to TCDD-elicited NAFLD. This evidence concerns the gene STAT5B and metabolic dysfunction-associated steatotic liver disease.